Regencell Bioscience: Extended Lock-Up Creates Significant Upside Potential

Core Viewpoint - Regencell Bioscience Holdings Limited (RGC) has experienced a remarkable increase of 23,745% in its stock price over the past year, leading to a market capitalization of $12.6 billion [1] Company Summary - RGC focuses on developing Traditional Chinese Medicine (TCM) remedies specifically for Attention Deficit Hyperactivity Disorder (ADHD) and Autism [1]